Search results
This review summarizes current evidence regarding the diagnosis, treatment, and prognosis of systemic lupus erythematosus.
7 maj 2024 · The primary goal of treatment is to achieve disease remission or quiescence, defined by minimal symptoms, low levels of autoimmune inflammatory markers, and minimal systemic glucocorticoid requirement while the patient is treated with maintenance doses of immunomodulatory or immunosuppressive medications.
Treatment goals include long-term patient survival, prevention of flares and organ damage, and optimisation of health-related quality of life. For organ-threatening or life-threatening SLE, treatment usually includes an initial period of high-intensity immunosuppressive therapy to control disease activity, followed by a longer period
28 mar 2019 · recommendations provide physicians and patients with updated consensus guidance on the management of SLE, combining evidence-base and expert-opinion. InTRoduCTIon Systemic lupus erythematosus (SLE) has variable presentation, course and prognosis. The wide acceptance and popularity of the first EULAR recommendations for its management, published
Of note, the 2019 recommendations counted a total of 33 recommendations belonging to 4 domains (goals of treatment, general principles of treatment, specific manifestations and comorbidities). The current update aligns with the EULAR SOPs to include a maximum 15 bullet point statements. To this end,
This monograph from the department of medicine of Johns Hopkins University is the most comprehensive review available of the symptoms, laboratory features, and treatment of systemic lupus erythematosus.
2 sty 2024 · The updated recommendations provide consensus guidance on the management of SLE, combining evidence and expert opinion.
